Skip to Content

1,027 Results Found

  • Review
  • Open Access
3 Citations
560 Views
37 Pages

Radiolabelled nanoparticles are increasingly investigated as multifunctional platforms for cancer imaging, biodistribution tracking, dosimetry, and radionuclide-based therapy. This review focuses on three representative inorganic nanoplatforms: zinc...

(This article belongs to the Section Molecular Nanoscience)
  • Article
  • Open Access
13 Citations
9,270 Views
14 Pages

Radiolabelling of Antigen and Liposomes for Vaccine Biodistribution Studies

  • Malou Henriksen-Lacey,
  • Vincent Bramwell and
  • Yvonne Perrie

A relatively simple and effective method to follow the movement of pharmaceutical preparations such as vaccines in biodistribution studies is to radiolabel the components. Whilst single radiolabelling is common practice, in vaccine systems containing...

(This article belongs to the Special Issue What's on Board in Pharmaceutics)
  • Review
  • Open Access
18 Citations
4,219 Views
20 Pages

Methods for Radiolabelling Nanoparticles: PET Use (Part 2)

  • Valeria Bentivoglio,
  • Michela Varani,
  • Chiara Lauri,
  • Danilo Ranieri and
  • Alberto Signore

20 October 2022

The use of radiolabelled nanoparticles (NPs) is a promising nuclear medicine tool for diagnostic and therapeutic purposes. Thanks to the heterogeneity of their material (organic or inorganic) and their unique physical and chemical characteristics, th...

(This article belongs to the Section Bio-Engineered Materials)
  • Review
  • Open Access
34 Citations
8,801 Views
22 Pages

Radiolabeled Dendrimers for Nuclear Medicine Applications

  • Lingzhou Zhao,
  • Meilin Zhu,
  • Yujie Li,
  • Yan Xing and
  • Jinhua Zhao

25 August 2017

Recent advances in nuclear medicine have explored nanoscale carriers for targeted delivery of various radionuclides in specific manners to improve the effect of diagnosis and therapy of diseases. Due to the unique molecular architecture allowing faci...

(This article belongs to the Special Issue Dendrimers in Medicine)
  • Communication
  • Open Access
3 Citations
2,645 Views
10 Pages

Radiolabeling Method for Lyophilizate for Dry Powder Inhalation Formulations

  • Kahori Miyamoto,
  • Tomomi Akita and
  • Chikamasa Yamashita

Human lung deposition data is non-mandatory for drug approval but very useful for the development of orally inhaled drug products. Lung deposition of inhaled drugs can be quantified by radionuclide imaging, for which one of the first considerations i...

(This article belongs to the Special Issue Drug Formulation and Process Optimization)
  • Review
  • Open Access
41 Citations
9,025 Views
24 Pages

Radiolabeled PSMA Inhibitors

  • Oliver C. Neels,
  • Klaus Kopka,
  • Christos Liolios and
  • Ali Afshar-Oromieh

13 December 2021

PSMA has shown to be a promising target for diagnosis and therapy (theranostics) of prostate cancer. We have reviewed developments in the field of radio- and fluorescence-guided surgery and targeted photodynamic therapy as well as multitargeting PSMA...

(This article belongs to the Special Issue Radiopharmaceuticals for Oncological Diseases)
  • Review
  • Open Access
35 Citations
5,254 Views
23 Pages

Radiolabeled Liposomes for Nuclear Imaging Probes

  • Ho Ying Low,
  • Chang-Tong Yang,
  • Bin Xia,
  • Tao He and ,
  • Winnie Wing Chuen Lam and
  • David Chee Eng Ng
  • + 1 author+ 0 author

28 April 2023

Quantitative nuclear imaging techniques are in high demand for various disease diagnostics and cancer theranostics. The non-invasive imaging modality requires radiotracing through the radioactive decay emission of the radionuclide. Current preclinica...

(This article belongs to the Special Issue Advance in Radiochemistry)
  • Communication
  • Open Access
3 Citations
2,454 Views
12 Pages

How Does the Concentration of Technetium-99m Radiolabeled Gold Nanoparticles Affect Their In Vivo Biodistribution?

  • Adamantia Apostolopoulou,
  • Evangelia-Alexandra Salvanou,
  • Aristeidis Chiotellis,
  • Nektarios N. Pirmettis and ,
  • Ioannis C. Pirmettis,
  • Stavros Xanthopoulos,
  • Przemysław Koźmiński and
  • Penelope Bouziotis
  • + 3 authors+ 0 author

20 May 2024

Gold nanoparticles (AuNPs) radiolabeled with therapeutic and diagnostic radioisotopes have been broadly studied as a promising platform for early diagnosis and treatment of many diseases including cancer. Our main goal for this study was the comparis...

(This article belongs to the Special Issue Nanomaterials in Medical Diagnosis and Therapy)
  • Article
  • Open Access
3 Citations
2,394 Views
20 Pages

Radiolabeling, Quality Control and In Vivo Imaging of Multimodal Targeted Nanomedicines

  • Phuoc-Vinh Nguyen,
  • Emilie Allard-Vannier,
  • Nicolas Aubrey,
  • Christine Labrugère-Sarroste and ,
  • Igor Chourpa,
  • Julien Sobilo,
  • Alain Le Pape and
  • Katel Hervé-Aubert
  • + 3 authors+ 0 author

Following our previous study on the development of EGFR-targeted nanomedicine (NM-scFv) for the active delivery of siRNA in EGFR-positive cancers, this study focuses on the development and the quality control of a radiolabeling method to track it in...

(This article belongs to the Special Issue Functionalized Nanoparticles in Cancer Therapeutics)
  • Article
  • Open Access
1 Citations
1,467 Views
21 Pages

Lutetium-177 Radiolabeled Gold Nanoparticles for Prostate Cancer Theranostics

  • Adamantia Apostolopoulou,
  • Evangelia-Alexandra Salvanou,
  • Christos Liolios,
  • Stavros Xanthopoulos and ,
  • Przemysław Koźmiński and
  • Penelope Bouziotis
  • + 1 author+ 0 author

Gold nanoparticles (AuNPs) have been extensively studied in cancer treatment research since they have special physicochemical characteristics such as facile surface functionalization with various chemical groups, low toxicity, favorable biocompatibil...

(This article belongs to the Special Issue Applications of Nanomaterials in Biomedical Imaging and Cancer Therapy: 4th Edition)
  • Article
  • Open Access
10 Citations
6,823 Views
14 Pages

Synthesis and 11C-Radiolabelling of 2-Carboranyl Benzothiazoles

  • Kiran B. Gona,
  • Jaya Lakshmi V. N. P. Thota,
  • Zuriñe Baz,
  • Vanessa Gómez-Vallejo and
  • Jordi Llop

23 April 2015

Dicarba-closo-dodecaboranes, commonly known as carboranes, possess unique physico-chemical properties and can be used as hydrophobic moieties during the design of new drugs or radiotracers. In this work, we report the synthesis of two analogues of 2...

(This article belongs to the Special Issue Recent Advances in Boron Chemistry)
  • Review
  • Open Access
465 Views
28 Pages

22 September 2026

Background/Objectives: MicroRNAs (miRNAs) are small non-coding RNAs (20–24 nucleotides) that regulate post-transcriptional gene expression and are involved in key biological processes, including proliferation and apoptosis. Dysregulation of miR...

(This article belongs to the Special Issue Advancing Precision Diagnosis and Therapy with Targeted Radiopharmaceuticals in Cancer and Systemic Diseases)
  • Systematic Review
  • Open Access
15 Citations
5,807 Views
34 Pages

Methods for Radiolabeling Nanoparticles (Part 3): Therapeutic Use

  • Valeria Bentivoglio,
  • Pallavi Nayak,
  • Michela Varani,
  • Chiara Lauri and
  • Alberto Signore

12 August 2023

Following previously published systematic reviews on the diagnostic use of nanoparticles (NPs), in this manuscript, we report published methods for radiolabeling nanoparticles with therapeutic alpha-emitting, beta-emitting, or Auger’s electron-...

(This article belongs to the Section Bio-Engineered Materials)
  • Review
  • Open Access
80 Citations
11,647 Views
17 Pages

In the last two decades, various nanomaterials have attracted increasing attention in medical science owing to their unique physical and chemical characteristics. Incorporating radionuclides into conventionally used nanomaterials can confer useful ad...

(This article belongs to the Special Issue Nanoparticle-Based Radiosensitization)
  • Review
  • Open Access
107 Citations
12,679 Views
23 Pages

Radiolabeled Antibodies for Cancer Imaging and Therapy

  • Sagun Parakh,
  • Sze Ting Lee,
  • Hui K. Gan and
  • Andrew M. Scott

11 March 2022

Radioimmunoconjugates consist of a monoclonal antibody (mAb) linked to a radionuclide. Radioimmunoconjugates as theranostics tools have been in development with success, particularly in hematological malignancies, leading to approval by the US Food a...

(This article belongs to the Special Issue Recent Developments of Nuclear Medicine in Cancer Diagnosis and Theranostics)
  • Article
  • Open Access
16 Citations
3,837 Views
14 Pages

Biodistribution of Mesoporous Carbon Nanoparticles via Technetium-99m Radiolabelling after Oral Administration to Mice

  • Maria Mamai,
  • Dimitra Giasafaki,
  • Evangelia-Alexandra Salvanou,
  • Georgia Charalambopoulou and ,
  • Theodore Steriotis and
  • Penelope Bouziotis
  • + 1 author+ 0 author

30 November 2021

The use of ordered mesoporous matrices, and in particular carbon-based mesoporous nanoparticles has shown great potential towards enhancing the bioavailability of orally administered drugs. Nevertheless, elucidation of the in vivo absorption, distrib...

(This article belongs to the Special Issue Nanoparticles for Bio-Medical Applications)
  • Article
  • Open Access
1 Citations
3,052 Views
11 Pages

Radiolabeling of Platelets with 99mTc-HYNIC-Duramycin for In Vivo Imaging Studies

  • Keresztély Merkel,
  • Dávid Szöllősi,
  • Ildikó Horváth,
  • Bálint Jezsó and ,
  • Zsolt Baranyai,
  • Krisztián Szigeti,
  • Zoltán Varga,
  • Imre Hegedüs,
  • Parasuraman Padmanabhan and
  • Domokos Máthé
  • + 7 authors+ 2 authors

4 December 2023

Following the in vivo biodistribution of platelets can contribute to a better understanding of their physiological and pathological roles, and nuclear imaging methods, such as single photon emission tomography (SPECT), provide an excellent method for...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Article
  • Open Access
22 Citations
8,096 Views
17 Pages

Dual Radiolabeling as a Technique to Track Nanocarriers: The Case of Gold Nanoparticles

  • Clinton Rambanapasi,
  • Nicola Barnard,
  • Anne Grobler,
  • Hylton Buntting and ,
  • Molahlehi Sonopo,
  • David Jansen,
  • Anine Jordaan,
  • Hendrik Steyn and
  • Jan Rijn Zeevaart
  • + 4 authors+ 0 author

16 July 2015

Gold nanoparticles (AuNPs) have shown great potential for use in nanomedicine and nanotechnologies due to their ease of synthesis and functionalization. However, their apparent biocompatibility and biodistribution is still a matter of intense debate...

(This article belongs to the Special Issue Preparation of Radiopharmaceuticals and Their Use in Drug Development)
  • Article
  • Open Access
9 Citations
4,914 Views
13 Pages

Antibody and Nanobody Radiolabeling with Copper-64: Solid vs. Liquid Target Approach

  • Ivanna Hrynchak,
  • Diana Cocioabă,
  • Alexandra I. Fonseca,
  • Radu Leonte and ,
  • Sérgio J. C. do Carmo,
  • Roxana Cornoiu,
  • Amílcar Falcão,
  • Dana Niculae and
  • Antero J. Abrunhosa
  • + 4 authors+ 0 author

Antibody and nanobody-based copper-64 radiopharmaceuticals are increasingly being proposed as theranostic tools in multiple human diseases. While the production of copper-64 using solid targets has been established for many years, its use is limited...

(This article belongs to the Section Photochemistry)
  • Article
  • Open Access
10 Citations
4,416 Views
16 Pages

Synthesis and In Vitro Evaluation of Gold Nanoparticles Functionalized with Thiol Ligands for Robust Radiolabeling with 99mTc

  • Adamantia Apostolopoulou,
  • Aristeidis Chiotellis,
  • Evangelia-Alexandra Salvanou,
  • Konstantina Makrypidi and ,
  • Charalampos Tsoukalas,
  • Fotis Kapiris,
  • Maria Paravatou-Petsotas,
  • Minas Papadopoulos,
  • Ioannis C. Pirmettis and
  • Penelope Bouziotis
  • + 6 authors+ 1 author

15 September 2021

Radiolabeled gold nanoparticles (AuNPs) have been widely used for cancer diagnosis and therapy over recent decades. In this study, we focused on the development and in vitro evaluation of four new Au nanoconjugates radiolabeled with technetium-99m (9...

(This article belongs to the Special Issue Nanobiotechnology for Drug Delivery System)
  • Feature Paper
  • Article
  • Open Access
23 Citations
4,082 Views
21 Pages

Preliminary Evaluation of Iron Oxide Nanoparticles Radiolabeled with 68Ga and 177Lu as Potential Theranostic Agents

  • Evangelia-Alexandra Salvanou,
  • Argiris Kolokithas-Ntoukas,
  • Christos Liolios,
  • Stavros Xanthopoulos and ,
  • Maria Paravatou-Petsotas,
  • Charalampos Tsoukalas,
  • Konstantinos Avgoustakis and
  • Penelope Bouziotis
  • + 3 authors+ 0 author

20 July 2022

Theranostic radioisotope pairs such as Gallium-68 (68Ga) for Positron Emission Tomography (PET) and Lutetium-177 (177Lu) for radioisotopic therapy, in conjunction with nanoparticles (NPs), are an emerging field in the treatment of cancer. The present...

(This article belongs to the Special Issue Nanoparticles in Diagnostic and Therapeutic Applications)
  • Review
  • Open Access
22 Citations
5,515 Views
19 Pages

Methods for Radiolabelling Nanoparticles: SPECT Use (Part 1)

  • Michela Varani,
  • Valeria Bentivoglio,
  • Chiara Lauri,
  • Danilo Ranieri and
  • Alberto Signore

20 October 2022

The use of nanoparticles (NPs) is rapidly increasing in nuclear medicine (NM) for diagnostic and therapeutic purposes. Their wide use is due to their chemical–physical characteristics and possibility to deliver several molecules. NPs can be syn...

(This article belongs to the Section Bio-Engineered Materials)
  • Review
  • Open Access
37 Citations
6,525 Views
31 Pages

Current State of Radiolabeled Heterobivalent Peptidic Ligands in Tumor Imaging and Therapy

  • Benedikt Judmann,
  • Diana Braun,
  • Björn Wängler,
  • Ralf Schirrmacher and ,
  • Gert Fricker and
  • Carmen Wängler
  • + 1 author+ 0 author

Over the past few years, an approach emerged that combines different receptor-specific peptide radioligands able to bind different target structures on tumor cells concomitantly or separately. The reason for the growing interest in this special field...

(This article belongs to the Special Issue Forward Thinking towards Theranostic (Radio)ligands Targeting the Tumor Microenvironment (TME))
  • Review
  • Open Access
38 Citations
5,688 Views
13 Pages

In Vivo Tracking of Extracellular Vesicles by Nuclear Imaging: Advances in Radiolabeling Strategies

  • Sara Almeida,
  • Liliana Santos,
  • Amílcar Falcão,
  • Célia Gomes and
  • Antero Abrunhosa

11 December 2020

Extracellular vesicles (EVs) are naturally secreted vesicles that have attracted a large amount of interest in nanomedicine in recent years due to their innate biocompatibility, high stability, low immunogenicity, and important role in cell-to-cell c...

(This article belongs to the Special Issue Molecular Imaging in Nanomedical Research)
  • Article
  • Open Access
554 Views
31 Pages

Comparative Study of NOTA-Derived Chelators: Synthesis, Al18F/177Lu Radiolabeling and Computational Analysis

  • Abir Dhimen,
  • Xavier Assfeld,
  • Gilles Karcher,
  • Charlotte Collet and
  • Samir Acherar

19 August 2026

The development of hybrid bifunctional chelators (BFCs) capable of efficiently coordinating both diagnostic and therapeutic radionuclides remains a major challenge in theranostic radiopharmaceutical design. Herein, two novel hybrid NOTA-derived chela...

(This article belongs to the Special Issue Research on Metal-Based Drugs and Their Mechanisms of Action)
  • Article
  • Open Access
11 Citations
8,048 Views
17 Pages

2 July 2015

Membrane type-1 matrix metalloproteinase (MT1-MMP or MMP-14) plays an important role in adverse cardiac remodelling. Here, we aimed to develop radiolabeled activatable cell penetrating peptides (ACPP) sensitive to MT1-MMP for the detection of elevate...

(This article belongs to the Special Issue Cell Penetrating Peptides (CPPs))
  • Review
  • Open Access
2 Citations
750 Views
46 Pages

Imaging of infections has the potential to improve clinical outcomes, but pathogen-specific imaging strategies are currently unavailable. Given their target specificity, antimicrobials may be useful as molecular imaging ligands to target infections....

(This article belongs to the Special Issue Recent Advances in Molecular Imaging and Therapy)
  • Proceeding Paper
  • Open Access
1,814 Views
8 Pages

Radiolabeled monoclonal antibodies represent a promising approach to integrate molecular imaging with immunotherapy for cancer diagnosis and treatment. These antibodies target immune checkpoints and tumor-associated antigens, enabling non-invasive vi...

(This article belongs to the Proceedings of The 1st International Online Conference by Antibodies)
  • Article
  • Open Access
3 Citations
3,480 Views
18 Pages

Isotopic Radiolabeling of Crizotinib with Fluorine-18 for In Vivo Pet Imaging

  • Malvika Sardana,
  • Louise Breuil,
  • Sébastien Goutal,
  • Maud Goislard and ,
  • Mikhail Kondrashov,
  • Etienne Marchal,
  • Florent L. Besson,
  • Christophe Dugave,
  • Gail Wrigley and
  • Fabien Caillé
  • + 10 authors+ 5 authors

15 December 2022

Crizotinib is a tyrosine kinase inhibitor approved for the treatment of non-small-cell lung cancer, but it is inefficient on brain metastases. Crizotinib is a substrate of the P-glycoprotein, and non-invasive nuclear imaging can be used to assess the...

(This article belongs to the Section Radiopharmaceutical Sciences)
  • Article
  • Open Access
3 Citations
3,016 Views
22 Pages

2 October 2025

The growing use of experimental radiopharmaceuticals for targeted radionuclide therapy (TRT) highlights the need for robust “in house” radiolabeling protocols. Among these, PSMA-ALB-56 is a PSMA ligand incorporating an albumin-binding moi...

(This article belongs to the Section Molecular Oncology)
  • Review
  • Open Access
75 Citations
15,473 Views
48 Pages

22 July 2013

The increasing application of positron emission tomography (PET) in nuclear medicine has stimulated the extensive development of a multitude of novel and versatile bioorthogonal conjugation techniques especially for the radiolabeling of biologically...

(This article belongs to the Collection Advances in Click Chemistry)
  • Review
  • Open Access
31 Citations
7,273 Views
19 Pages

Nanobody-Based Theranostic Agents for HER2-Positive Breast Cancer: Radiolabeling Strategies

  • Ivanna Hrynchak,
  • Liliana Santos,
  • Amílcar Falcão,
  • Célia M. Gomes and
  • Antero J. Abrunhosa

4 October 2021

The overexpression of human epidermal growth factor 2 (HER2) in breast cancer (BC) has been associated with a more aggressive tumor subtype, poorer prognosis and shorter overall survival. In this context, the development of HER2-targeted radiotracers...

(This article belongs to the Section Biochemistry)
  • Communication
  • Open Access
19 Citations
9,094 Views
8 Pages

Biodistribution of a Radiolabeled Antibody in Mice as an Approach to Evaluating Antibody Pharmacokinetics

  • Kevin J. H. Allen,
  • Rubin Jiao,
  • Mackenzie E. Malo,
  • Connor Frank and
  • Ekaterina Dadachova

(1) Background: Monoclonal antibodies are used in the treatment of multiple conditions including cancer, autoimmune disorders, and infectious diseases. One of the initial steps in the selection of an antibody candidate for further pre-clinical develo...

(This article belongs to the Special Issue Drug Delivery Technology Development in Canada)
  • Article
  • Open Access
5 Citations
8,472 Views
14 Pages

Further Insights into Brevetoxin Metabolism by de Novo Radiolabeling

  • Kevin Calabro,
  • Jean-Marie Guigonis,
  • Jean-Louis Teyssié,
  • François Oberhänsli and ,
  • Jean-Pierre Goudour,
  • Michel Warnau,
  • Marie-Yasmine Dechraoui Bottein and
  • Olivier P. Thomas
  • + 3 authors+ 0 author

10 June 2014

The toxic dinoflagellate Karenia brevis, responsible for early harmful algal blooms in the Gulf of Mexico, produces many secondary metabolites, including potent neurotoxins called brevetoxins (PbTx). These compounds have been identified as toxic agen...

(This article belongs to the Collection Marine and Freshwater Toxins)
  • Article
  • Open Access
9 Citations
3,337 Views
19 Pages

Radiolabeling of Micro-/Nanoplastics via In-Diffusion

  • Alexandra Stricker,
  • Stephan Hilpmann,
  • Alexander Mansel,
  • Karsten Franke and
  • Stefan Schymura

30 September 2023

Micro- and nanoplastics are emerging pollutants with a concerning persistence in the environment. Research into their environmental impact requires addressing challenges related to sensitively and selectively detecting them in complex ecological medi...

(This article belongs to the Section Environmental Nanoscience and Nanotechnology)
  • Review
  • Open Access
115 Citations
20,790 Views
27 Pages

Radiolabeling of Nanoparticles and Polymers for PET Imaging

  • Katharina Stockhofe,
  • Johannes M. Postema,
  • Hanno Schieferstein and
  • Tobias L. Ross

2 April 2014

Nanomedicine has become an emerging field in imaging and therapy of malignancies. Nanodimensional drug delivery systems have already been used in the clinic, as carriers for sensitive chemotherapeutics or highly toxic substances. In addition, those n...

(This article belongs to the Special Issue Radiopharmaceutical Chemistry between Imaging and Radioendotherapy)
  • Article
  • Open Access
53 Citations
6,789 Views
21 Pages

Gold Nanoparticles as Boron Carriers for Boron Neutron Capture Therapy: Synthesis, Radiolabelling and In Vivo Evaluation

  • Krishna R. Pulagam,
  • Kiran B. Gona,
  • Vanessa Gómez-Vallejo,
  • Jan Meijer and ,
  • Carolin Zilberfain,
  • Irina Estrela-Lopis,
  • Zuriñe Baz,
  • Unai Cossío and
  • Jordi Llop
  • + 4 authors+ 0 author

7 October 2019

Background: Boron Neutron Capture Therapy (BNCT) is a binary approach to cancer therapy that requires accumulation of boron atoms preferentially in tumour cells. This can be achieved by using nanoparticles as boron carriers and taking advantage of th...

(This article belongs to the Special Issue Advances in Materials Derived from Polyhedral Boron Clusters)
  • Article
  • Open Access
28 Citations
4,187 Views
12 Pages

Hydroxyapatite and Titanium Dioxide Nanoparticles: Radiolabelling and In Vitro Stability of Prospective Theranostic Nanocarriers for 223Ra and 99mTc

  • Petra Suchánková,
  • Ekaterina Kukleva,
  • Eva Nykl,
  • Pavel Nykl and ,
  • Michal Sakmár,
  • Martin Vlk and
  • Ján Kozempel
  • + 2 authors+ 0 author

20 August 2020

Hydroxyapatite and titanium dioxide are widely used materials in a broad spectrum of branches. Due to their appropriate properties such as a large specific surface area, radiation stability or relatively low toxicity, they could be potentially used a...

(This article belongs to the Special Issue Isotopes Labeled Nanoparticles)
  • Article
  • Open Access
17 Citations
4,263 Views
19 Pages

Chelator-Free/Chelator-Mediated Radiolabeling of Colloidally Stabilized Iron Oxide Nanoparticles for Biomedical Imaging

  • Sofia Papadopoulou,
  • Argiris Kolokithas-Ntoukas,
  • Evangelia-Alexandra Salvanou,
  • Anastasios Gaitanis and ,
  • Stavros Xanthopoulos,
  • Konstantinos Avgoustakis,
  • Maria Gazouli,
  • Maria Paravatou-Petsotas,
  • Charalampos Tsoukalas and
  • Penelope Bouziotis
  • + 6 authors+ 1 author

25 June 2021

The aim of this study was to develop a bioimaging probe based on magnetic iron oxide nanoparticles (MIONs) surface functionalized with the copolymer (p(MAA-g-EGMA)), which were radiolabeled with the positron emitter Gallium-68. The synthesis of the h...

(This article belongs to the Special Issue Isotopes Labeled Nanoparticles)
  • Article
  • Open Access
7 Citations
3,797 Views
30 Pages

Synthesis, 123I-Radiolabeling Optimization, and Initial Preclinical Evaluation of Novel Urea-Based PSMA Inhibitors with a Tributylstannyl Prosthetic Group in Their Structures

  • Lutfi A. Hasnowo,
  • Maria S. Larkina,
  • Evgenii Plotnikov,
  • Vitalina Bodenko and ,
  • Feruza Yuldasheva,
  • Elena Stasyuk,
  • Stanislav A. Petrov,
  • Nikolai Y. Zyk,
  • Aleksei E. Machulkin and
  • Mekhman S. Yusubov
  • + 11 authors+ 6 authors

Prostate-specific membrane antigen (PSMA) has been identified as a target for the development of theranostic agents. In our current work, we describe the design and synthesis of novel N-[N-[(S)-1,3-dicarboxypropyl]carbamoyl]-(S)-L-lysine (DCL) urea-b...

(This article belongs to the Special Issue Novel Researches and Perspectives on Prostate Cancer)
  • Article
  • Open Access
69 Citations
6,746 Views
15 Pages

A Proof-of-Concept Study on the Therapeutic Potential of Au Nanoparticles Radiolabeled with the Alpha-Emitter Actinium-225

  • Evangelia-Alexandra Salvanou,
  • Dimitris Stellas,
  • Charalampos Tsoukalas,
  • Barbara Mavroidi and ,
  • Maria Paravatou-Petsotas,
  • Nikolaos Kalogeropoulos,
  • Stavros Xanthopoulos,
  • Franck Denat,
  • Gautier Laurent and
  • Penelope Bouziotis
  • + 7 authors+ 2 authors

Actinium-225 (225Ac) is receiving increased attention for its application in targeted radionuclide therapy, due to the short range of its emitted alpha particles in conjunction with their high linear energy transfer, which lead to the eradication of...

(This article belongs to the Special Issue Targeted Radionuclide Tumor Therapy)
  • Review
  • Open Access
23 Citations
6,266 Views
14 Pages

The Different Strategies for the Radiolabeling of [211At]-Astatinated Radiopharmaceuticals

  • Jie Gao,
  • Mei Li,
  • Jingjing Yin,
  • Mengya Liu and ,
  • Hongliang Wang,
  • Jin Du and
  • Jianguo Li
  • + 2 authors+ 0 author

Astatine-211 (211At) has emerged as a promising radionuclide for targeted alpha therapy of cancer by virtue of its favorable nuclear properties. However, the limited in vivo stability of 211At-labeled radiopharmaceuticals remains a major challenge. T...

  • Review
  • Open Access
664 Views
22 Pages

Advances in Nuclear Medicine Diagnostics: The Promise of Radiolabeled Dendrimers

  • Agnieszka Maria Kołodziejczyk and
  • Bolesław T. Karwowski

4 August 2026

One of the most widespread causes of mortality is cancer, and its early diagnosis is a key element of modern medicine. A crucial role is played by imaging techniques such as positron emission tomography (PET), single-photon emission computed tomograp...

(This article belongs to the Special Issue Radiolabeled Nanoparticles: Molecular Design, Targeting, Therapy, and Imaging)
  • Review
  • Open Access
20 Citations
7,771 Views
20 Pages

Radiolabelled Aptamers for Theranostic Treatment of Cancer

  • Umair Khalid,
  • Chris Vi,
  • Justin Henri,
  • Joanna Macdonald and ,
  • Peter Eu,
  • Giovanni Mandarano and
  • Sarah Shigdar
  • + 2 authors+ 0 author

24 December 2018

Cancer has a high incidence and mortality rate worldwide, which continues to grow as millions of people are diagnosed annually. Metastatic disease caused by cancer is largely responsible for the mortality rates, thus early detection of metastatic tum...

(This article belongs to the Special Issue Aptamer-Based Diagnostics and Therapeutics)
  • Review
  • Open Access
17 Citations
4,844 Views
27 Pages

Extracellular vesicles (ECVs) have been abandoned as bio-inspired drug delivery systems (DDS) in the biomedical field. ECVs have a natural ability to cross over extracellular and intracellular barriers, making them superior to manufactured nanopartic...

(This article belongs to the Special Issue Recent Advances in Exosomes as Drug Carriers)
  • Article
  • Open Access
17 Citations
8,268 Views
23 Pages

27 May 2014

Dendritic structures, being highly homogeneous and symmetric, represent ideal scaffolds for the multimerization of bioactive molecules and thus enable the synthesis of compounds of high valency which are e.g., applicable in radiolabeled form as multi...

(This article belongs to the Special Issue Dendrimers in Medicine and Biotechnology)
  • Review
  • Open Access
115 Citations
17,374 Views
37 Pages

Overview of Radiolabeled Somatostatin Analogs for Cancer Imaging and Therapy

  • Romain Eychenne,
  • Christelle Bouvry,
  • Mickael Bourgeois,
  • Pascal Loyer and ,
  • Eric Benoist and
  • Nicolas Lepareur
  • + 1 author+ 0 author

2 September 2020

Identified in 1973, somatostatin (SST) is a cyclic hormone peptide with a short biological half-life. Somatostatin receptors (SSTRs) are widely expressed in the whole body, with five subtypes described. The interaction between SST and its receptors l...

(This article belongs to the Special Issue Radiolabeled Compounds for Diagnosis and Treatment of Cancer)
  • Review
  • Open Access
63 Citations
14,518 Views
28 Pages

Radiolabeled Cetuximab Conjugates for EGFR Targeted Cancer Diagnostics and Therapy

  • Wiebke Sihver,
  • Jens Pietzsch,
  • Mechthild Krause,
  • Michael Baumann and ,
  • Jörg Steinbach and
  • Hans-Jürgen Pietzsch
  • + 1 author+ 0 author

5 March 2014

The epidermal growth factor receptor (EGFR) has evolved over years into a main molecular target for the treatment of different cancer entities. In this regard, the anti-EGFR antibody cetuximab has been approved alone or in combination with: (a) che...

(This article belongs to the Special Issue Radiopharmaceutical Chemistry between Imaging and Radioendotherapy)
  • Review
  • Open Access
25 Citations
4,499 Views
34 Pages

Nanoradiopharmaceuticals: Design Principles, Radiolabeling Strategies, and Biomedicine Applications

  • Andrés Núñez-Salinas,
  • Cristian Parra-Garretón,
  • Daniel Acuña,
  • Sofía Peñaloza and ,
  • Germán Günther,
  • Soledad Bollo,
  • Francisco Arriagada and
  • Javier Morales
  • + 3 authors+ 0 author

Nanoradiopharmaceuticals integrate nanotechnology with nuclear medicine to enhance the precision and effectiveness of radiopharmaceuticals used in diagnostic imaging and targeted therapies. Nanomaterials offer improved targeting capabilities and grea...

(This article belongs to the Section Nanomedicine and Nanotechnology)
  • Review
  • Open Access
16 Citations
6,015 Views
18 Pages

Current Status of Radiolabeled Monoclonal Antibodies Targeting PSMA for Imaging and Therapy

  • Mohammed Abusalem,
  • Lucia Martiniova,
  • Sarita Soebianto,
  • Louis DePalatis and
  • Gregory Ravizzini

13 September 2023

Prostate cancer (PCa) is one of the most prevalent cancer diagnoses among men in the United States and in several other developed countries. The prostate specific membrane antigen (PSMA) has been recognized as a promising molecular target in PCa, whi...

(This article belongs to the Section Methods and Technologies Development)

of 21